|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.1350 - 0.1532|
|52 Week Range||0.0378 - 0.2450|
|Beta (5Y Monthly)||4.23|
|PE Ratio (TTM)||13.93|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Toronto, Ontario--(Newsfile Corp. - June 21, 2021) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the "Company" or "Datametrex") is pleased to announce that further to its press release of March 23, 2021, it has completed the acquisition of Medi-Call Inc. ("Medi-Call" or "Target"), an arm's length, British Columbia based private telemedicine company.The acquisition of Medi-Call was completed by way of a share exchange agreement dated June 18, 2021 between the Company, Medi-Call ..
Toronto, Ontario--(Newsfile Corp. - June 16, 2021) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the "Company" or "Datametrex") is pleased to announce that its senior management will be hosting an investor update webinar on Tuesday, June 22, 2021, at 1:45 p.m. EST to discuss the Company's future developments on the Artificial Intelligence technologies, Telemedicine, and COVID-19 test kits. Shareholders, investors, media representatives and other stakeholders are invited to join t
Reported the record achievement in the history of the Company. Datametrex has filed on SEDAR its financial ...